氨溴特罗佐治毛细支气管炎337例疗效观察

The clinical efficacy of anbroxol hydrochloride and clenbuterol hydrochloride oral solution for children with capillarity bronchitis

目的观察氨溴特罗(氨溴索及克伦特罗的复合制剂)治疗毛细支气管炎的临床疗效。方法将337例毛细支气管炎患儿随机分为治疗组169例,对照组168例。两组均采用抗感染、止咳、化痰、雾化、吸痰等常规治疗。治疗组加用氨溴特罗口服液口服,观察比较两组疗效。结果治疗组在喘憋消失、咳嗽消失天数及哮鸣音和湿啰音消失天数、住院天数等方面均较对照组明显缩短,差异均有统计学意义(P<0.01);治疗组总有效率高于对照组,两组不良反应发生率差异无统计学意义。结论氨溴特罗治疗毛细支气管炎可提高治愈率,缩短病程,安全、有效。

Objective To observe the clinical efficacy of anbroxol hydrochloride and clenbuterol hydrochloride oral solution for children with capillarity bronchitis.Methods 337 children were involved and randomly divided into control（168） and treatment group（169）.On the basis of theraphy,169 patients in treatment group were treated with anbroxol hydrochloride and clenbuterol hydrochloride oral solution.Results The disappearance days including wheezing,cough,wheezing voice,moist rales,and hospitalization days of the treatment group,was significantly shorter than the control group（P0.01）,the total efficiency of treatment group was higher than control group.The adverse reaction rate was no significant difference.Conclusion Anbroxol hydrochloride and clenbuterol hydrochloride oral solution could enhance the cure rate,reduces the course of an illness effectively,security and effectiveness.